glp-1 cancer reduction drugs cut breast risk by 30%? Not so fast Glucagon-like peptide-1 medicines and cancer

Symptoms of Mast Cell Activation Syndrome (MCAS) At first, people may confuse the symptoms of this syndrome with exposure to allergens or anaphylaxis because they resemble allergic reactions

The promise of GLP-1s to address these concerns is understandably appealing, but we lack adequate research to guide evidence-based prescribing and patient decisionmaking for this population

Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer

This method enabled the visualization of the injured myocardial area supplied by occluded coronary arteries with significantly greater sensitivity than conventional techniques

GSH is a key intracellular thiol that helps neutralize ROS and maintain the balance between protein thiols and disulfides

While these treatments are not designed for overall weight loss, they can refine and contour areas like the waist, arms, thighs, chin, and jawline